Polycystic Ovarian Syndrome - Pipeline Assessment And Market Forecasts To 2017 Aarkstore Enterprise

Aarkstore announce a new report "Polycystic Ovarian Syndrome - Pipeline Assessment

and Market Forecasts to 2017 " through its vast collection of market research report.

Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts to 2017 ; is a new report from industry analysis specialists. The report is an essential source of information and analysis on the global Polycystic Ovarian Syndrome (PCOS) market. The report identifies the key trends shaping and driving the global PCOS market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PCOS sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

We estimate the Polycystic Ovarian Syndrome (PCOS) market to be worth $706m in 2009 and projects it to grow at a CAGR of 0.6% to reach $742m in 2017. The market is expected to decrease by 30.1% from $805m in 2011 to $563m in 2012. The decrease in the market will be due to the expiry of Letrozoles patent in the year 2011.

The market will gain pace from 2013 and will grow to $742m in 2017. The slow growth rate is largely because of the under diagnosis of this syndrome. However, the market is driven by an increasing prevalence rate, diagnosis rate and treatment seeking rate. The rise in the prescription population will contribute to the growth of the PCOS market. Due to the presence of a large number of generic products and a weak pipeline, this market will not grow at a significant rate.

Scope

- The report provides information on the key drivers and challenges of the Polycystic Ovarian Syndrome (PCOS) market. Its scope includes:

- Annualized global PCOS market revenues data from 2001 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as estrogen antagonists, female gamete inhibitor, insulin secretion inhibitor, HMG CoA inhibitor, Gastric and pancreatic lipase inhibitor and fats break down inhibitor.

- Analysis of the current and future competition in the global PCOS market. Key market players covered are Merck KGaA, Catalysis SL and Amylin Pharma.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PCOS therapeutics market

Reasons to buy

- The report will enhance your decision making capability. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global PCOS therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global PCOS therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- Whats the next big thing in the global PCOS therapeutics market landscape? - Identify, understand and capitalize.

For more information, please visit:

http://www.aarkstore.com/reports/Polycystic-Ovarian-Syndrome-Pipeline-Assessment-and-Market-Forecasts-to-2017-65062.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Online Slots Consistently Produces Winners in UK Online Casino Market 6 Reasons To Opt For Social Media Missouri Marketing Marketing Cost of Acquisition for Dental Practices Read Before Joining-Fortune Hi Tech Marketing Review Oao Tnk-bp Holding - Swot Analysis - Market Research Report On Aarkstore Enterprise Email Marketing 101 1000 Calorie Challenge Scam- - 1000 Calorie Challenge offers you a sound and reasonable eating plan Profitability through Advanced Organizational Structure Stantec Inc. - Swot Analysis - Market Research Report On Aarkstore Enterprise Pancreatic Cancer - Pipeline Assessment And Market Forecasts To 2017 Aarkstore Enterprise Non-hodgkins Lymphoma (nhl) - Pipeline Assessment And Market Forecasts To 2017 Aarkstore Enterpri The Real Benefits of Outsourcing to Telemarketing Companies Hypnotherapy and Cigarette smoking: Locating a Profitable Way to Quit